The widespread adoption of drug-eluting stents (DES) has led to a decline in repeat revascularizations with no increase in mortality or myocardial infarction (MI), an observational study of US Medicare patients reveals.

David Malenka (Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA) and team compared outcomes of patients undergoing non-emergency coronary stenting before and after the introduction of DES.

Uncertainty remains over the trade-off between safety and effectiveness of DES, since trials have suggested they are associated with increased risks for both early and late stent thrombosis - in turn associated with a high risk for ...

Esta siendo redirigido al contenido completo...